Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (2007) (ISBN 0309109868) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Building a National Framework for the Establishment of Regulatory Science for Drug Development:Workshop Summary (2011) (ISBN 0309158893) Yeonwoo Lebovitz, Rebecca English, and Anne Claiborne; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• The Safe Use Initiative and Health Literacy: Workshop Summary (2010) (ISBN 0309159318) Cori Vancheri, Rapporteur; Roundtable on Health Literacy; Institute of Medicine


• Preventing Medication Errors: Quality Chasm Series (2007) (ISBN 0309101476) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010) (ISBN 0309151295) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• Assessing and Improving Value in Cancer Care:Workshop Summary (2009) (ISBN 0309138140) Adam Schickedanz, Rapporteur; Institute of Medicine


• Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act (2012) (ISBN 0309225493) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA); Institute of Medicine


• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (2012) (ISBN 0309261163) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Scientific Standards for Studies on Modified Risk Tobacco Products (2012) (ISBN 0309223989) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Leadership Commitments to Improve Value in Health Care:Finding Common Ground: Workshop Summary (2009) (ISBN 030911053X) LeighAnne Olsen, W. Alexander Goolsby, and J. Michael McGinnis; Roundtable on Evidence-Based Medicine


• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary (2012) (ISBN 0309222141) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Accelerating the Development of Biomarkers for Drug Safety:Workshop Summary (2009) (ISBN 0309131243) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine